Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.11.500111022720.1892
Domestic EquitiesMax Healthcare Institute Ltd.5.91698933210.3875
Domestic EquitiesCipla Ltd.5.6646649439.9447
Domestic EquitiesApollo Hospitals Enterprise Ltd.5.1754123869.0858
Domestic EquitiesDivi's Laboratories Ltd.5.0622137218.8871
Domestic EquitiesDr. Reddy's Laboratories Ltd.4.4675623057.8430
Domestic EquitiesLupin Ltd.3.4221288536.0078
Domestic EquitiesFortis Healthcare Ltd.2.9507563615.1801
Domestic EquitiesTorrent Pharmaceuticals Ltd.2.8833136055.0619
Domestic EquitiesLaurus Labs Ltd.2.3675403014.1564
Domestic EquitiesAurobindo Pharma Ltd.2.0975300183.6823
Domestic EquitiesGlenmark Pharmaceuticals Ltd.1.9763178273.4695
Domestic EquitiesMankind Pharma Ltd.1.8236142223.2014
Domestic EquitiesAlkem Laboratories Ltd.1.778854933.1228
Domestic EquitiesBiocon Ltd.1.3937614222.4467
Domestic EquitiesIPCA Laboratories Ltd.1.3263160242.3284
Domestic EquitiesZydus Lifesciences Ltd.1.2409231142.1785
Domestic EquitiesNarayana Hrudayalaya ltd.0.910482151.5982
Domestic EquitiesGland Pharma Ltd.0.853585151.4983
Domestic EquitiesSyngene International Ltd.0.7690208261.3501
Domestic EquitiesPiramal Pharma Ltd.0.7326687011.2862
Domestic EquitiesAjanta Pharma Ltd.0.732550221.2860
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Ltd.0.711948641.2498
Domestic EquitiesGlobal Health Ltd.0.657392611.1539
Domestic EquitiesCohance Lifesciences Ltd.0.4238131820.7440
Total 66.8383 117.3396
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd.0.4896 0.8596
Cash & Cash Equivalents and Net AssetsAccrued Interest0.0002 0.0004
Cash & Cash Equivalents and Net AssetsNet Receivables/(Payables)-0.3947 -0.6930
Total 0.0951 0.1670
Overseas EquitiesELI LILLY & CO6.8282124611.9874
Overseas EquitiesJOHNSON & JOHNSON3.930737286.9006
Overseas EquitiesABBVIE INC3.173327355.5709
Overseas EquitiesMERCK & CO.INC2.066238683.6273
Overseas EquitiesNOVARTIS AG1.955529433.4330
Overseas EquitiesABBOTT LABORATORIES1.769426943.1064
Overseas EquitiesTHERMO FISHER SCIENTIFIC INC1.76125853.0919
Overseas EquitiesINTUITIVE SURGICAL INC1.62475562.8523
Overseas EquitiesAMGEN INC1.46818342.5773
Overseas EquitiesNovo Nordisk A/S1.253349842.2003
Overseas EquitiesGILEAD SCIENCES INC1.231819212.1625
Overseas EquitiesDANAHER CORP1.15329982.0246
Overseas EquitiesMEDTRONIC PLC1.065919861.8713
Overseas EquitiesSTRYKER CORP1.00815331.7698
Overseas EquitiesVERTEX PHARMACEUTICALS INC0.87943981.5438
Overseas EquitiesRegeneron Pharmaceuticals Inc0.64401621.1306
Overseas EquitiesBECTON DICKINSON AND CO0.44004450.7724
Overseas EquitiesAGILENT TECHNOLOGIES INC0.34424400.6042
Overseas EquitiesIQVIA HOLDINGS INC0.30942640.5432
Overseas EquitiesILLUMINA INC0.16012390.2810
Total 33.0666 58.0508
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.